---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-005308"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2025-02-13T23:59:59+00:00"
generated_at: "2026-05-26T22:23:34.544506+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners provides preliminary 2025 guidance; proposes $30M note from largest shareholder

## Summary
- Preliminary 2025 revenue guidance of $1.35B-$1.5B; Adjusted EBITDA of $(35)M to $5M.
- At-risk members guidance of 108k-118k for FY2025.
- Proposed $30M unsecured promissory note and warrants from largest shareholder, terms similar to Dec 2024 financing.
- CEO states $130M+ EBITDA growth initiatives on track; targeting profitability in 2025.
- Full 2025 guidance to be issued with Q4 2024 earnings.

## SEC filing metadata
- accession: 0001628280-25-005308
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2025-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000162828025005308/0001628280-25-005308-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000162828025005308/piii-20250213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-005308
- JSON: https://secwatch.observer/filing/0001628280-25-005308.json
- Plain text: https://secwatch.observer/filing/0001628280-25-005308.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.